Related Insights
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Podcast
Rare endpoints: Delivering on unmet patient needs
May 7, 2024
Playbook
Mitigating risk, protecting potential: Practical strategies that position cell and gene therapy development for success
Mar 28, 2023
Blog
CAR-T boxed warnings: regulatory precedents and opportunities
Feb 9, 2024
Podcast
CAR-T boxed warnings: What comes next?
Mar 6, 2024
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Blog
CAR-T product development: an assessment of FDA’s final guidance for industry
Feb 27, 2024
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Article
Three ways to improve your chances that insurers will pay for a new CGT
Feb 18, 2021
Article
Regulatory, clinical and logistics challenges of ATMPs in clinical research
Apr 22, 2021
Article
Q&A Project Optimus: What you need to know
Oct 11, 2022
Podcast
RBQM Podcast Series | Episode 3: Staying within the Guardrails: How to Push the Boundaries in a Highly Regulated Industry
Jun 16, 2022